Pentwater Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Pentwater Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,511,700	Closed	-$45.3M	–	182
2019 Q4	$45.3M	Buy	+7,511,700	New	+$43.5M	0.74%	26

Pentwater Capital Management's ACHN Position: Q1 2020 in Review

Pentwater Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 7,511,700 shares — an estimated $45.3M sold.

Pentwater Capital Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $45.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Pentwater Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Pentwater Capital Management sold 7,511,700 Achillion Pharmaceuticals shares in Q1 2020, an estimated $45.3M.
Pentwater Capital Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Pentwater Capital Management's Achillion Pharmaceuticals position peaked at $45.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Pentwater Capital Management's 13F filing for Q1 2020, filed 15 May 2020.